Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.

Scott Mintzer; Eugen Trinka; Günter Kraemer; Inna Chervoneva; Konrad J Werhahn

doi:10.1111/epi.14554

Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.

Scott Mintzer
, Eugen Trinka (Co-author)
, Günter Kraemer
, Inna Chervoneva
, Konrad J Werhahn

Department of Neurology, Neurological Intensive Care Medicine and Neurorehabilitation

Research output: Contribution to journal › Original Article › peer-review

51 Citations (Web of Science)

Original language	English
Pages (from-to)	1899-1907
Journal	EPILEPSIA
Volume	59
Issue number	10
DOIs	https://doi.org/10.1111/epi.14554
Publication status	Published - 2018

Keywords

C-REACTIVE PROTEIN
CONTROLLED-RELEASE CARBAMAZEPINE
NEWLY-DIAGNOSED EPILEPSY
ANTIEPILEPTIC DRUGS
DOUBLE-BLIND
SERUM-CHOLESTEROL
MONOTHERAPY
ACID

Access to Document

10.1111/epi.14554

Cite this

@article{dda7611d2f9d4eaeb6488e764003506e,

title = "Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.",

keywords = "C-REACTIVE PROTEIN, CONTROLLED-RELEASE CARBAMAZEPINE, NEWLY-DIAGNOSED EPILEPSY, ANTIEPILEPTIC DRUGS, DOUBLE-BLIND, SERUM-CHOLESTEROL, MONOTHERAPY, ACID",

author = "Scott Mintzer and Eugen Trinka and G{\"u}nter Kraemer and Inna Chervoneva and Werhahn, \{Konrad J\}",

note = "Trinka, E: Paracelsus Med Univ, Dept Neurol, Salzburg, Austria",

year = "2018",

doi = "10.1111/epi.14554",

language = "English",

volume = "59",

pages = "1899--1907",

journal = "EPILEPSIA",

issn = "0013-9580",

publisher = "Wiley Verlag ",

number = "10",

}

TY - JOUR

T1 - Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.

AU - Mintzer, Scott

AU - Trinka, Eugen

AU - Kraemer, Günter

AU - Chervoneva, Inna

AU - Werhahn, Konrad J

N1 - Trinka, E: Paracelsus Med Univ, Dept Neurol, Salzburg, Austria

PY - 2018

Y1 - 2018

KW - C-REACTIVE PROTEIN

KW - CONTROLLED-RELEASE CARBAMAZEPINE

KW - NEWLY-DIAGNOSED EPILEPSY

KW - ANTIEPILEPTIC DRUGS

KW - DOUBLE-BLIND

KW - SERUM-CHOLESTEROL

KW - MONOTHERAPY

KW - ACID

U2 - 10.1111/epi.14554

DO - 10.1111/epi.14554

M3 - Original Article

C2 - 30178473

SN - 0013-9580

VL - 59

SP - 1899

EP - 1907

JO - EPILEPSIA

JF - EPILEPSIA

IS - 10

ER -